Pharmabiz

US FDA grants orphan drug and rare paediatric disease designations to Grünenthal’s tegacorat to treat Duchenne muscular dystrophy

US FDA grants orphan drug and rare paediatric disease designations to Grünenthal’s tegacorat to treat Duchenne muscular dystrophy: Aachen, Germany Thursday, July 9, 2026, 18:00 ...
Pharmabiz

Health minister to lay foundation stone of ICMR Centre for High Altitude Medicine and Public Health Research in HP

Health minister to lay foundation stone of ICMR Centre for High Altitude Medicine and Public Health Research in HP: Our Bureau, New Delhi Thursday, July 9, 2026, 17:50 Hrs [IST] U ...
Pharmabiz

Applied StemCell & RoosterBio enter strategic partnership to develop and commercialize scalable iPSC-based bioprocess solutions

Applied StemCell & RoosterBio enter strategic partnership to develop and commercialize scalable iPSC-based bioprocess solutions: Milpitas, California Thursday, July 9, 2026, 17:00 ...
Pharmabiz

Cetaphil launches new AM/PM Antioxidant Serum Duo in India

Cetaphil, the globally trusted skincare brand from Swiss dermatology company Galderma, has expanded its Cetaphil skincare ...
Pharmabiz

US FDA grants breakthrough therapy designation to Merck’s enpatoran in lupus patients with active skin manifestations

US FDA grants breakthrough therapy designation to Merck’s enpatoran in lupus patients with active skin manifestations: Darmstadt, Germany Thursday, July 9, 2026, 16:00 Hrs [IST] ...
Pharmabiz

United Nations HRC adopts resolution on neglected tropical diseases at its sixty-second session in Geneva

United Nations HRC adopts resolution on neglected tropical diseases at its sixty-second session in Geneva: Geneva Thursday, July 9, 2026, 15:00 Hrs [IST] Resolution 62/27 on “Hu ...
Pharmabiz

Maxivision Super Speciality Eye Hospitals appoints Badrinarayan Srikanth as group CEO

Maxivision Super Speciality Eye Hospitals announced the appointment of Badrinarayan Srikanth as its group chief executive ...
Pharmabiz

Dr Reddy's Labs delays semaglutide supply over API issue

Dr Reddy's Laboratories stated that certain batches of semaglutide were found to be out of specification due to an issue associated with the active pharmaceutical ingredient (API) used in the product.
Pharmabiz

Novo Nordisk GBS to extend financial support of Rs. 1.75 crore for advanced pharmacometrics at MAHE

Novo Nordisk GBS to extend financial support of Rs. 1.75 crore for advanced pharmacometrics at MAHE: Our Bureau, Bengaluru Thursday, July 9, 2026, 13:30 Hrs [IST] Novo Nordisk Glo ...
Pharmabiz

BioLineRx & Hemispherian announce new preclinical data demonstrating strong synergistic effect between GLIX1 and PARP inhibitor in a patient-derived ovarian cancer xenograft model

BioLineRx & Hemispherian announce new preclinical data demonstrating strong synergistic effect between GLIX1 and PARP inhibitor in a patient-derived ovarian cancer xenograft model ...
Pharmabiz

Union health ministry launches integrated training strategy to strengthen primary healthcare workforce

Union health ministry launches integrated training strategy to strengthen primary healthcare workforce: Our Bureau, Mumbai Thursday, July 9, 2026, 11:15 Hrs [IST] Union Ministry o ...
Pharmabiz

Sino Biopharmaceutical enters exclusive license agreement with AstraZeneca for development, manufacturing and commercialization of PDE3/4 inhibitor, TQC3721

Sino Biopharmaceutical enters exclusive license agreement with AstraZeneca for development, manufacturing and commercialization of PDE3/4 inhibitor, TQC3721: Hong Kong Thursday, J ...